Factors predicting the early biochemical response to [۱۷۷Lu]Lu-PSMA therapy in patients with metastatic castration resistant prostate cancer

Publish Year: 1401
نوع سند: مقاله ژورنالی
زبان: English
View: 182

This Paper With 7 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

این Paper در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IRJNM-30-2_006

تاریخ نمایه سازی: 8 تیر 1401

Abstract:

Introduction: Targeted radionuclide therapy with [۱۷۷Lu]Lu-prostate-specific membrane antigen (PSMA) has shown promising results for the treatment of castration-resistant prostate cancer (mCRPC). Nevertheless, a proportion of patients do not respond to this therapy. Here, we aimed to evaluate the prognostic significance of the pretreatment pathologic and laboratory factors for the prediction of biochemical response to the first cycle of [۱۷۷Lu]Lu-PSMA therapy.Methods: In this retrospective study, mCRPC patients, referred for [۱۷۷Lu]Lu-PSMA therapy, were included. We retrieved the data of patients, undergone [۱۷۷Lu]Lu-PSMA, from March ۲۰۱۹ to March ۲۰۲۱. Multiple baseline pathologic and laboratory parameters were extracted and correlated with the response to the first cycle. The prostate-specific antigen (PSA) level was evaluated six weeks after [۱۷۷Lu]Lu-PSMA therapy for the biochemical response.Results: Forty-three patients with a mean age of ۶۹.۸±۱۰.۲ were included. Bone and visceral metastases were present in ۸۱.۴% and ۱۴.۰% of the patients, respectively. Except for two, all patients had received hormone- and chemotherapy. The mean PSA level was ۱۸۹.۹±۲۵۹.۰ at baseline. Following one cycle of [۱۷۷Lu]Lu-PSMA, “≥ ۱۰% PSA response” and “≥ ۵۰% PSA response” were seen in ۸۱.۴% and ۴۴.۲% of the patients, respectively. Patients with higher baseline PSA more frequently had ≥ ۱۰% PSA response (p= ۰.۰۰۴). Also, the reduction in the PSA level correlated with baseline PSA (p=۰.۰۱۳, r=۰.۳۷۵).Conclusion: [۱۷۷Lu]Lu-PSMA therapy results in the biochemical response in a considerable number of patients after one cycle. In nearly half of patients, PSA declines more than ۵۰%. Higher baseline PSA is correlated with the level of PSA response.

Authors

Ahmed Al-Timimi

Research Center for Nuclear Medicine, Tehran University of Medical Sciences, Tehran, Iran

Reyhaneh Manafi-Farid

Research Center for Nuclear Medicine, Tehran University of Medical Sciences, Tehran, Iran

Babak Fallahi

Research Center for Nuclear Medicine, Tehran University of Medical Sciences, Tehran, Iran

Davood Beiki

Research Center for Nuclear Medicine, Tehran University of Medical Sciences, Tehran, Iran

Emran Askari

Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Alireza Rezaei

Khatam PET/CT Center, Khatam Al-Anbia Hospital, Tehran, Iran

Zohreh Adinehpour

Khatam PET/CT Center, Khatam Al-Anbia Hospital, Tehran, Iran

Mohammad Eftekhari

Research Center for Nuclear Medicine, Tehran University of Medical Sciences, Tehran, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, ...
  • Kirby M, Hirst C, Crawford ED. Characterizing the castration-resistant prostate ...
  • Barber TW, Singh A, Kulkarni HR, Niepsch K, Billah B, ...
  • Puranik AD, Dromain C, Fleshner N, Sathekge M, Pavel M, ...
  • Conteduca V, Mosca A, Brighi N, de Giorgi U, Rescigno ...
  • Sartor O, de Bono J, Chi KN, Fizazi K, Herrmann ...
  • Manafi-Farid R, Harsini S, Saidi B, Ahmadzadehfar H, Herrmann K, ...
  • Kim YJ, Kim YI. Therapeutic responses and survival effects of ...
  • Scher HI, Morris MJ, Stadler WM, Higano C, Basch E, ...
  • Ahmadzadehfar H, Eppard E, Kürpig S, Fimmers R, Yordanova A, ...
  • Rahbar K, Bode A, Weckesser M, Avramovic N, Claesener M, ...
  • Seifert R, Kessel K, Schlack K, Weckesser M, Bögemann M, ...
  • Rahbar K, Ahmadzadehfar H, Kratochwil C, Haberkorn U, Schäfers M, ...
  • Gafita A, Fendler WP, Hui W, Sandhu S, Weber M, ...
  • Leibovici D, Spiess PE, Agarwal PK, Tu SM, Pettaway CA, ...
  • Ahmadzadehfar H, Wegen S, Yordanova A, Fimmers R, Kürpig S, ...
  • Soydal C, Araz M, Urun Y, Nak D, Ozkan E, ...
  • Izumi K, Lin WJ, Miyamoto H, Huang CK, Maolake A, ...
  • Matsubara N, Chi KN, Özgüroğlu M, Rodriguez-Antolin A, Feyerabend S, ...
  • Viglialoro R, Esposito E, Zanca R, Gessi M, Depalo T, ...
  • نمایش کامل مراجع